Cryptococcal antigen among HIV1-infected individuals in north-central Nigeria

Document Type : Original Articles


1 Department of Medical Microbiology and Parasitology, College of Health Sciences, University of Ilorin, Ilorin, Nigeria

2 Department of Medicine, College of Health Sciences, University of Ilorin, Ilorin, Nigeria.


Background and Purpose: The potential for the invasion of the central nervous system by Cryptococcus species is underscored by the presence of this organism in the blood of immunocompromised individuals. Early adoption of sensitive methods for the diagnosis of Cryptococcus species will reduce the high morbidity and mortality associated with this disease. Regarding this, the aim of the present research was to detect cryptococcal antigen among HIV1- infected individuals in north-central Nigeria.
Materials and Methods: This prospective cross-sectional study was carried out on HIV-1 infected individuals accessing care at three health facilities in north-central Nigeria between November 2014 and March 2017. For the purpose of the study, blood samples were collected from 300 HIV1-infected individuals within the age group of 3-65 years. The CD4+ T-cell count was determined, and the samples were analyzed for cryptococcal antigenemia using the methods of lateral flow assay (LFA) and culture technique.
Results: Cryptococcus antigen was detected in 19.67% (59/300) of the patients, and only 25.4% (15/59) of the LFA-positive samples showed Cryptococcus species growth on Sabouraud dextrose agar after 3 days. Furthermore, fungal growth was observed in one of the specimens, which was LFA negative. Additionally, 30 of the 59 LFA-positive patients had cryptococcal antigen in their serum with a CD4+ T-cell count of < 150 cells/mm3.
Conclusion: As the findings of the present study indicated, infection with Cryptococcus species is a problem among HIV-infected patients in the region under study. Therefore, all HIV patients, especially those with a CD4+ T-cell count of < 150 cells/mm3, referring to the HAART clinics in Nigeria, should be screened for cryptococcal antigen.


1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009; 23(4):525-30.
2. Saha D, Xess I, Biswas A, Bhowmik DM, Padma MV. Detection of Cryptococcus by conventional, serological and molecular
methods. J Med Microbiol. 2009; 58(Pt 8):1098-105.
3. Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis. 1991; 13(6):1163-9.
4. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill JR, et al. Clinical practice guidelines for the management of cryptococcal disease: update by the infectious diseases society of America. Clin Infect Dis. 2010; 50(3):291-322.
5. Severo CB, Gazzoni AF, Severo LC. Pulmonary cryptococcosis. J Bras Pneumol. 2009; 35(11):3713-44.
6. Rajasingham R, Wake RM, Beyene T, Katende A, Letang E, Boulware DR. Cryptococcal meningitis diagnostics and screening in the era of point-of-care laboratory testing. J Clin Microbiol. 2019; 57(1):e01238.
7. World Health Organization. Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: December 2011. Geneva: World Health Organization; 2011.
8. French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002; 16(7):1031-8.
9. Salami AK, Ogunmodede JA, Fowotade A, Nwabuisi C, Wahab KW, Desalu OO, et al. Cryptococcal meningitis in a newly diagnosed AIDS patient: a case report. West Afr J Med. 2009; 28(5):343-5.
10. Abdulkarim AA, Katibi OS, Mohammed SS, Ekundayo HA, Fadeyi A, Alarape AJ. Cryptococcal meningitis: a rare opportunistic infection in an HIV infected Nigerian boy: a case report. Trop J Health Sci. 2012; 19(2):37-9.
11. UNAIDS. HIV/AIDS in Nigeria; pushing for the last mile. Nigeria HIV/AIDS indicator and impact survey report. Geneva: World Health Organization; 2019.
12. Tanner DC, Weinstein MP, Fedorciw B, Joho KL, Thorpe JJ, Reller L. Comparison of commercial kits for detection of cryptococcal antigen. J Clin Microbiol. 1994; 32(7):1680-4.
13. Dzoyem JP, Kechia FA, Ngaba GP, Lunga PK, Lohoue PJ. Prevalence of cryptococcosis among HIV-infected patients in Yaounde, Cameroon. Afr Health Sci. 2012; 12(2):129-33.
14. Beyene T, Woldeamanuel Y, Asrat D, Ayana G, Boulware DR. Comparison of cryptococcal antigenemia between antiretroviral naive and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia. PLoS One. 2013; 8(10):e75585.
15. Chukwuanukwu R, Manafa P, Iloghalu E, Onyenekwe C, Ifeanyichukwu M, Mbamalu C. Cryptococcus neoformans antigenemia in HIV positive pregnant women attending PMTCT clinic in South Eastern Nigeria. J Biol Agric Healthcare. 2013; l3(18):15-21.
16. Abubakar AO, Maikai BV, Musa BO, Olayinka AT. Public health implications of cryptococcal infection among HIV patients on antiretroviral therapy in hospital in Shika, Nigeria. Online J Public Health Inform. 2014; 6:61-3.
17. Joseph G, Ogbaini–Emovon E, Okwara BU, Onunu A, Kubeyinje E. Prevalence of disseminated cryptococcosis among human immunodeficiency virus infected patients in Benin city, Nigeria. Br J Med Med Res. 2015; 6(7):715–22.
18. Osazuwa OF, Dirisu O, Okunghae E. Cryptococcal antigenemia in anti–retroviral Naïve AIDS patients: prevalence and its association with CD4 cell count. Acta Med Iran. 2012; 50(5):344-7.
19. Ogba OM, Abia-Bassey L. Cryptococcal antigenemia among HIV seropositive patients accessing care in antiretroviral therapy (ART) clinics in Calabar, South Southern Nigeria. J Microbiol Infect. 2015; 1:2.
20. Gomerep SS, Idoko JA, Ladep NG, Ugoya SO, Obaseki D, Agbaji OA, et al. Frequency of cryptococcal meningitis in HIV-1 infected patients in North Central Nigeria. Niger J Med. 2010; 19(4):395-9.
21. Mamoojee Y, Shakoor S, Gorton RL, Sarfo S, Appiah L T, Norman B, et al. Low seroprevalence of cryptococcal antigenaemia in patients with advanced HIV infection enrolling in an antiretroviral programme in Ghana. Trop Med Int Health. 2011; 16(1):53-6.
22. World Health Organization. Guidelines on the diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: World Health Organization; 2018.
23. Mahmoudi LB, Platt JL, Graham JP. The integration of water, sanitation and hygiene services into the US President's Emergency Plan for AIDS relief: a qualitative study. Global
Public Health. 2015; 10(1):1-4.
24. Shah HS, Patel DA, Vegad MM. Evaluation of conventional and serological methods for rapid diagnosis of cryptococcal meningitis in HIV seropositive patients at tertiary care hospital. Natl J Community Med. 2011; 2(3):354-7.